Cath Lab Services Market Research, 2032
The global cath lab services market was valued at $46.0 billion in 2022, and is projected to reach $78.2 billion by 2032, growing at a CAGR of 5.4% from 2022 to 2032.
Cath lab, or catheterization laboratory, is a type of medical facility where treatments are performed involving maneuvering long, thin tubes (catheters) inside a patient's body. They are most used in the diagnosis and treatment of cardiovascular conditions, such as heart disease or arrhythmias. The procedure is performed to assess and repair a damaged blood vessel as well as place stents to widen a blocked artery. Other uses for cath labs include catheter-based surgery and catheter-based treatments of various conditions, such as atrial fibrillation.
Cardiac and brain & spine diseases treated in cath labs include coronary artery disease, aortic aneurysm, congenital heart defects, valvular heart disease, atherosclerosis, arrhythmias, cerebrovascular accident (stroke), carotid artery disease, aortic dissection/aneurysm, arteriovenous malformation (AVM), intracranial aneurysm, and hemorrhagic stroke.
Historical overview
The cath lab services market size was analyzed qualitatively and quantitatively from 2022 to 2032. The cath lab services market experienced growth at a CAGR of around 5.4% from 2022 to 2032. Most of the growth of cath lab services market size during this period was derived from North America owing to rise in the number of service providers for cath lab procedures and increase in f population suffering from chronic diseases such as cardiovascular diseases and brain and spine disorders.
Market Dynamics
The global cath lab services market Growth is majorly driven by high presence of cath lab, increase in prevalence of cardiovascular disorders, and technological advancements for development of cath lab. Moreover, increase in prevalence of cardiac diseases is expected to propel the growth of cath lab services market. Cardiac diseases are diagnosed in a cath lab using a variety of imaging techniques, including angiography, echocardiography, and others such as cardiac catheterization. In addition, cardiac catheterization is used to assess the function of the heart and its valves. This involves inserting a catheter into the arteries or veins and using contrast dye to visualize the blood flow in and around the heart. The results of these tests can be used to diagnose and treat a variety of cardiac diseases.
The cardiac diseases which are diagnosed or treated in cath lab are coronary artery disease, heart valve disease, congenital heart defects, aortic aneurysm, peripheral artery disease, atrial fibrillation, hypertrophic cardiomyopathy, pulmonary hypertension, pericardial effusion, and endomyocardial fibrosis. Thus, rise in incidence of cardiac diseases is expected to increase in number the demand for diagnostic and therapeutic cath lab procedures, which boosts the growth of the cath lab services market opportunity.
For instance, according to the British Heart Foundation, Heart, and Circulatory Disease statistics, it was reported that in 2022, around 1,139,140 people are suffering from heart and circulatory diseases in the UK. As per the same source, it was estimated that around 650,681 male and 488,320 female population are suffering from heart and circulatory diseases in the UK. Moreover, according to the American Heart Association, globally, it was estimated that in 2020, 244.1 million people were living with ischemic heart disease (IHD), and it was more prevalent in males than in females (141.0 and 103.1 million people, respectively).
Rise in the prevalence of brain and spine diseases is expected to drive the growth of cath lab services market forecast. For instance, therapeutic procedures such as aneurysm repair, angioplasty, arteriovenous malformation (AVM) treatment, carotid stents, mechanical thrombectomy for ischemic stroke, treatment of head and neck tumors, diagnosis of cervical, cerebral, and spinal conditions are conducted in cath labs. Thus, increase in prevalence of brain and spine diseases will increase the demand for diagnostic and therapeutic procedures in cath lab, which notably contributes toward the growth of the market.
For instance, according to the American Society of Clinical Oncology (ASCO), it was reported that in 2020, around 308,102 people were diagnosed with a primary brain or spinal cord tumor over the globe. As per the same source, it was estimated that around 5,230 children under the age of 20 will also be diagnosed with a central nervous system (CNS) tumor in the U.S. in 2023.
Moreover, according to the World Health Organization, in 2022 it was reported that lifetime risk of developing a stroke has increased by 50% over the last 17 years and now 1 in 4 people is estimated to have a stroke in their lifetime. Thus, increase in number of brain and spine diseases is expected to propel the number of diagnostic and therapeutic procedures in cath lab, which fuels the growth of market.
Rise in the number of geriatric population is anticipated to increase in the prevalence of cardiac diseases, thus, this factor is expected to fuel the growth of cath lab services market. This is attributed to the fact that the geriatric population is highly susceptible to cardiac diseases due to a variety of factors such as lack of physical activities, frailty, obesity, and other diseases such as diabetes and arteriosclerosis. Aging is associated with a natural decrease in the elasticity of arteries, which further leads to blockages in coronary arteries.
Moreover, the elderly population is more likely to have risk factors such as high blood pressure, high cholesterol, and diabetes, which can further increase their risk of developing cardiac diseases. Therefore, surge in aging population along with sedentary lifestyle increases the risk of developing heart diseases, which, in turn, drives the growth of the cath lab services market.
On the other hand, high cost of certain cath lab diagnostic and therapeutic procedures can limit the growth of the market, as many potential patients or organizations may not have the financial capacity to cover the cost. This can prevent the market from accommodating additional providers and can act as a deterrent for potential customers.
Segmental Overview
The global cath lab services market share is segmented into service type, application, and service provider. Depending on service type, the market is segmented into diagnostic and therapeutic. Depending on application, it is bifurcated into cardiac and brain & spine. On the basis of service provider, it is segregated into hospital and individual cath lab. Region wise, the cath lab services market share is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By service type
The therapeutic segment is expected to dominate the cath lab services industry owing to rise in adoption of therapeutic cath lab procedures for treatment of chronic diseases such as cardiovascular diseases and brain & spine disorders.
By application
The cardiac segment is projected to exhibit the highest growth of cath lab services industry in the near future due to increase in prevalence of cardiovascular diseases and rise in awareness among the people regarding availability of cath lab procedures for diagnosis of cardiac diseases.
By service provider
The hospitals segment is projected to exhibit the highest growth in the near future due to increase in expenditure by government to develop healthcare infrastructure.
By Region
North America garnered the largest share in 2022, and is expected to continue this trend during the forecast period owing to high presence of service providers for cath lab procedures and rise in population suffering from cardiovascular and brain & spine diseases. Moreover, rise in number of populations suffering from cardiovascular diseases such as coronary artery disease, arrhythmias, heart valve disease, and other structural heart defects is anticipated to fuel the demand for cath lab procedures and boosts the growth of market. For instance, according to the Center for Disease Control and Prevention (CDC), it was reported that around 20.1 million adults ages 20 years and older have coronary artery disease (CAD).
However, Asia-Pacific is expected to exhibit fastest growth during the forecast period owing to increase in number of cath labs and rapid technological advancement for development of cath lab. Moreover, technological advancements in cath labs are anticipated to boost the growth of market. For instance, in April 2023, St George Private Hospital in Ramsay Health Care in Australia, unveiled new technology in its cardiac catheterization lab, designed to provide a clearer picture for doctors and lessen the amount of radiation present. The new Cannon Alihenix will be used for interventional angiography procedures, which involve X-ray technology being used to assist a specialist guiding a catheter through a patient’s major arteries.
Competition analysis
Some of the major companies that operate in the global cath lab market include Canyon vista medical center, Ochsner Rush Health, Henryford, Alberta Health Services, Adventist Health Bakersfield, alliance medical associates, Campbell Country Health, InHealth Group, Netcare Hospitals, Ramsay Health Care, and USA Health.
Recent technological advancements in the cath lab services market
In April 2023, St George Private Hospital in Ramsay Health Care organization, a healthcare service provider, unveiled new technology in its cardiac catheterization lab, designed to provide a clearer picture for doctors and lessen the amount of radiation present. The new Cannon Alihenix will be used for interventional angiography procedures which involve X-ray technology being used to assist a specialist guiding a catheter through a patient’s major arteries.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cath lab services market analysis from 2022 to 2032 to identify the prevailing cath lab services market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cath lab services market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cath lab services market trends, key players, market segments, application areas, and market growth strategies.
Cath Lab Services Market Report Highlights
| Aspects | Details |
 Market Size By 2032 | USD 78.2 billion |
 Growth Rate | CAGR of 5.4% |
 Forecast period | 2022 - 2032 |
 Report Pages | 351 |
 By Service Type |
|
 By Application |
|
 By Service provider |
|
 By Region |
|
 Key Market Players | Alliance Medical Associates, Alberta Health Services, Adventist Health Bakersfield, Canyon vista medical center, Inhealthgroup, Campbell Country Health, Netcare Hospitals, Henryford health, Ramsayhealth, Ochsner Rush Health |
Analyst Review
This section provides various opinions of the top-level CXOs in the global cath lab industry. In accordance with several interviews conducted, the cath lab services market is expected to witness notable growth with rise in number of cath labs and technological advancements in cath lab. For instance, in April 2023, St George Private Hospital in Ramsay Health Care, a healthcare service provider, unveiled new technology in its cardiac catheterization lab, designed to provide a clearer picture for doctors and lessen the amount of radiation present. The new Cannon Alihenix will be used for interventional angiography procedures, which involve X-ray technology being used to assist a specialist guiding a catheter through a patient’s major arteries.
Moreover, in June 2022, HCA Florida North Florida Hospital ((NFH), a part of HCA Florida Healthcare, announced that its cardiovascular cath program has opened its 5th hybrid cath lab to support the growth of its endovascular services. NFH’s 5th Cath Lab includes an advanced imaging system. This cath labs service is used to maximized both cardiac diagnostic and interventional procedures with a fully motorized tilting table, high definition 3-dimensional image reconstruction, endovascular aneurysm repair (EVAR) planning software, quantitative vessel analysis software, radiation dose optimization software, and a large display monitor.
The top companies that hold the market share in cath lab services market are Canyon vista medical center, Ochsner Rush Health, Henryford, Alberta Health Services, Adventist Health Bakersfield, and Campbell Country Health.
Asia-Pacific is anticipated to witness lucrative growth during the forecast period, owing to rise in expenditure by government organization to develop the healthcare sector, increase in the prevalence of cardiac diseases and increase in the number of geriatric populations.
The key trends in the cath lab services market are high presence of cath lab and rise in number of cath lab procedures.
The base year for the report is 2022.
10 cath lab companies are profiled in the report
The total market value of cath lab market is $46,096.86 million in 2022.
The forecast period in the report is from 2023 to 2032.
High cost of cath lab procedures is restraining factor for cath lab services market.
Loading Table Of Content...
Loading Research Methodology...
